Joseph K. Agyin, Ph.D., M.B.A.

Dr. Agyin received his Ph.D. in Organic Chemistry from Purdue University, where he developed novel strategies to design and synthesize polyfunctional steroids and norbornene compounds and further studied their antenna-initiated photochemistry. After graduation, he joined the Cancer Therapy & Research Center’s Institute for Drug Development (IDD) at San Antonio, Texas, as a postdoctoral research fellow and later promoted to Assistant Member. At the IDD, Dr. Agyin designed and synthesized novel analogues of a lead preclinical anticancer agent, as part of a multidisciplinary team of researchers, including cancer biologists and clinicians. He later joined the University of Texas Health Science Center at San Antonio as Assistant Professor in the Biochemistry department where his research program focused on the design and synthesis of novel, bone-targeted proteasome inhibitors for treatment of multiple myeloma and breast cancer. His programmatic interests include preclinical cancer drug development, medicinal chemistry, design and synthesis of small molecules, structure optimization, and biological evaluation of anticancer compounds. Dr. Agyin has an M.B.A from Duke University.